Joel E. Tepper
About
Joel E. Tepper is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Joel E. Tepper has authored 247 papers receiving a total of 14.5k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Oncology, 108 papers in Surgery and 108 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joel E. Tepper's work include Colorectal and Anal Carcinomas (65 papers), Colorectal Cancer Surgical Treatments (64 papers) and Colorectal Cancer Treatments and Studies (43 papers). Joel E. Tepper is often cited by papers focused on Colorectal and Anal Carcinomas (65 papers), Colorectal Cancer Surgical Treatments (64 papers) and Colorectal Cancer Treatments and Studies (43 papers). Joel E. Tepper collaborates with scholars based in United States, Canada and France. Joel E. Tepper's co-authors include Christopher G. Willett, Herman D. Suit, Robert J. Mayer, Donna Hollis, Donna Niedzwiecki, William F. Sindelar, Leonard L. Gunderson, Eli Glatstein, Richard M. Goldberg and Steven A. Rosenberg and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Nature Nanotechnology.
In The Last Decade
Joel E. Tepper
243 papers receiving 14.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Joel E. Tepper United States | 65 | 8.1k | 6.9k | 6.5k | 1.3k | 1.2k | 247 | 14.5k | ||
| Christopher G. Willett United States | 71 | 9.6k 1.2× | 7.7k 1.1× | 9.1k 1.4× | 1.7k 1.2× | 1.5k 1.3× | 308 | 17.4k | ||
| A. Norman United Kingdom | 58 | 5.9k 0.7× | 5.9k 0.9× | 5.2k 0.8× | 1.2k 0.9× | 539 0.4× | 138 | 12.3k | ||
| Christian Wittekind Germany | 59 | 10.7k 1.3× | 4.5k 0.7× | 9.4k 1.4× | 2.3k 1.7× | 1.3k 1.1× | 218 | 17.3k | ||
| Thomas F. Pajak United States | 57 | 6.1k 0.8× | 9.4k 1.4× | 9.6k 1.5× | 1.7k 1.3× | 1.0k 0.9× | 165 | 19.6k | ||
| Leonard L. Gunderson United States | 66 | 11.6k 1.4× | 10.5k 1.5× | 13.7k 2.1× | 705 0.5× | 1.1k 1.0× | 218 | 20.6k | ||
| Cornelis Verhoef Netherlands | 53 | 6.1k 0.7× | 3.1k 0.5× | 3.3k 0.5× | 1.4k 1.0× | 1.1k 0.9× | 476 | 11.0k | ||
| Andy Trotti United States | 51 | 5.9k 0.7× | 7.0k 1.0× | 6.3k 1.0× | 1.7k 1.2× | 868 0.7× | 143 | 16.6k | ||
| Ross A. Abrams United States | 54 | 10.0k 1.2× | 6.3k 0.9× | 6.0k 0.9× | 1.3k 1.0× | 3.0k 2.5× | 181 | 14.5k | ||
| Prajnan Das United States | 48 | 6.0k 0.7× | 3.5k 0.5× | 5.6k 0.9× | 542 0.4× | 870 0.7× | 323 | 9.8k | ||
| Jacques Bernier Switzerland | 39 | 3.6k 0.4× | 6.7k 1.0× | 4.9k 0.8× | 1.2k 0.9× | 368 0.3× | 112 | 13.4k |
Countries citing papers authored by Joel E. Tepper
Since
Specialization
Citations
This map shows the geographic impact of Joel E. Tepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel E. Tepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel E. Tepper more than expected).
Fields of papers citing papers by Joel E. Tepper
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Joel E. Tepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel E. Tepper. The network helps show where Joel E. Tepper may publish in the future.
Co-authorship network of co-authors of Joel E. Tepper
This figure shows the co-authorship network connecting the top 25 collaborators of Joel E. Tepper. A scholar is included among the top collaborators of Joel E. Tepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel E. Tepper. Joel E. Tepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Moon, Andrew M., et al.. (2024). Biochemical Safety of SBRT to Multiple Intrahepatic Lesions for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 443–454.
2.
Worrell, Stephanie G., Karyn A. Goodman, Nasser K. Altorki, et al.. (2023). The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. The Annals of Thoracic Surgery. 117(1). 15–32.
3.
Wang, Kyle & Joel E. Tepper. (2021). Radiation therapy‐associated toxicity: Etiology, management, and prevention. CA A Cancer Journal for Clinicians. 71(5). 437–454.
4.
Sanoff, Hanna K., Dominic H. Moon, Dominic T. Moore, et al.. (2019). Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer. Nanomedicine Nanotechnology Biology and Medicine. 18. 189–195.
5.
Myung, Ja Hye, Michael J. Eblan, Joseph M. Caster, et al.. (2018). Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture. Clinical Cancer Research. 24(11). 2539–2547.
6.
Moon, Dominic H., Autumn J. McRee, A. William Blackstock, et al.. (2017). Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S66–S66.
7.
Chera, Bhishamjit S., Robert J. Amdur, Joel E. Tepper, et al.. (2017). Two-year clinical outcomes of de-intensified chemoradiotherapy for low-risk HPV-associated oropharyngeal squamous cell carcinoma.. Journal of Clinical Oncology. 35(15_suppl). 6044–6044.
8.
Tian, Xi, Minh Nguyen, Henry P. Foote, et al.. (2016). CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α. Cancer Research. 77(1). 112–122.
9.
VanderWalde, Noam A., Allison M. Deal, Hyman B. Muss, et al.. (2016). Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 98(4). 850–857.
10.
Chera, Bhishamjit S., Robert J. Amdur, Joel E. Tepper, et al.. (2015). A Prospective Phase II Trial of Deintensified Chemoradiation Therapy for Low Risk HPV Associated Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 93(3). S2–S2.
11.
Davies, Janine M., Dimitri G. Trembath, Allison M. Deal, et al.. (2011). Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy. Radiation Oncology. 6(1). 114–114.
12.
Kimple, Randall J., Angelina V. Vaseva, Adrienne D. Cox, et al.. (2010). Radiosensitization of Epidermal Growth Factor Receptor/HER2–Positive Pancreatic Cancer Is Mediated by Inhibition of Akt Independent of Ras Mutational Status. Clinical Cancer Research. 16(3). 912–923.
13.
Qu, Pingping, Haitao Chu, Joseph G. Ibrahim, et al.. (2008). Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis. British Journal of Cancer. 99(12). 2001–2005.
14.
Tepper, Joel E., et al.. (2007). Rectal Cancer Radiotherapy. The Cancer Journal. 13(3). 204–209.
15.
Baxter, Nancy N., et al.. (2005). Prostat Işınlaması Sonrası Rektal Kanser Riskinde Artış: Popülasyon Temelli Bir Çalışma. Gastroenterology. 1(2). 85–90.
16.
Meyerhardt, Jeffrey A., Joel E. Tepper, Donna Niedzwiecki, et al.. (2004). Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114. Journal of Clinical Oncology. 22(4). 648–657.
17.
Martenson, James A., Rodolfo E. Urias, Stephen R. Smalley, et al.. (1995). Radiation therapy quality control in a clinical trial of adjuvant postoperative treatment for rectal cancer. International Journal of Radiation Oncology*Biology*Physics. 32(1). 51–55.
18.
Landry, Jerome C., et al.. (1990). Patterns of failure following curative resection of gastric carcinoma. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1357–1362.
19.
Tepper, Joel E., W. C. Wood, & A. M. Cohen. (1989). Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 16(6). 1437–1444.
20.
Willett, Christopher G., et al.. (1987). Adjuvant Postoperative Radiation Therapy for Colonic Carcinoma. Annals of Surgery. 206(6). 694–698.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Christopher G. Willett Breakdown of academic impact, for papers by A. Norman Breakdown of academic impact, for papers by Christian Wittekind Breakdown of academic impact, for papers by Thomas F. Pajak Breakdown of academic impact, for papers by Leonard L. Gunderson Breakdown of academic impact, for papers by Cornelis Verhoef Breakdown of academic impact, for papers by Andy Trotti Breakdown of academic impact, for papers by Ross A. Abrams Breakdown of academic impact, for papers by Prajnan Das Breakdown of academic impact, for papers by Jacques Bernier